81306 Nudt15 gene common variants
Also known as: NUDT15 pharmacogenomic test, thiopurine sensitivity testing
Nudix Hydrolase 15 (NUDT15) gene analysis for common variants affecting thiopurine metabolism and chemotherapy response.
In Plain Language
Chemotherapy response prediction test; Drug toxicity risk assessment
Clinical Context
Identifies NUDT15 variants that predict thiopurine toxicity in acute lymphoblastic leukemia and other malignancies treated with 6-mercaptopurine.
RVU Information
CPT 81306 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81306?
CPT 81306 (Nudt15 gene common variants) is a Pathology & Lab code. Nudix Hydrolase 15 (NUDT15) gene analysis for common variants affecting thiopurine metabolism and chemotherapy response.
Who uses CPT code 81306?
CPT 81306 is used by Pathology, Oncology, Pharmacogenomics. Identifies NUDT15 variants that predict thiopurine toxicity in acute lymphoblastic leukemia and other malignancies treated with 6-mercaptopurine.
When is CPT 81306 used?
Identifies NUDT15 variants that predict thiopurine toxicity in acute lymphoblastic leukemia and other malignancies treated with 6-mercaptopurine.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.